"Solidifying Global Partnerships"

Medytox said on Oct. 21 that it had successfully concluded the 2026 Medytox Global Symposium, held on Oct. 19 at Lotte Hotel World in Songpa-gu, Seoul.


Medytox invited more than 260 local medical professionals and partner company representatives from 21 countries, including China, Thailand, Brazil, Saudi Arabia and the Dominican Republic, to strengthen exchanges and lay the foundation for long-term cooperation.


A view of the venue of the "2026 Medytox Global Symposium," held at Lotte Hotel World in Songpa-gu, Seoul, on the 19th. Medytox

A view of the venue of the "2026 Medytox Global Symposium," held at Lotte Hotel World in Songpa-gu, Seoul, on the 19th. Medytox

View original image

Seo Guil, director of Modelo Dermatology Clinic; Hong Giung, director of SAM Skin Plastic Surgery; and Noh Nakgyeong, director of the Cheongdam Dosan-daero branch of Leaders Dermatology Clinic, spoke at the symposium. They shared global aesthetic medicine trends and their clinical experience with Medytox's leading products, including botulinum toxin products, hyaluronic acid fillers and fat-reduction injections.


The sessions focused on the characteristics of Coretox, a 150 kDa botulinum toxin product; SHAPE Technology, Medytox's proprietary technology used in the hyaluronic acid filler Neuramis; and cholic acid, a key ingredient in Newbijou, Medytox's next-generation fat-reduction injection, as well as what sets it apart.



A Medytox official said, "It was an opportunity to share Medytox's strengths and vision with medical professionals and partners from key countries and further strengthen our partnerships. Beyond the title of 'first,' we will continue to grow as a company that sets new standards for the global aesthetics industry and leads a paradigm shift."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing